Trial Profile
A retrospective, single centre, non interventional study assessing kinetics of Regulatory CD4 T Cells in Heart Recipients Under Induction Therapy With One-single Dose versus Two-dose Basiliximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary)
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 25 Apr 2018 New trial record
- 14 Apr 2018 Results presented at the 38th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation